CD14 and neoplasm: Thus, the present study aimed to characterize the phenotype of macrophages (CD45+HLA-DR+CD11b+CD14+) recovered from tumor samples from patients diagnosed with GBM and submitted to immunotherapy with dendritic cells, correlating their frequency and phenotype with the survival of these patients.